Showing results (371-380 of 464) with videos related to
Sort By:
Pageof 47
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
[A case of massive pancreatic neuroendocrine carcinoma successfully treated with surgical resection and postoperative everolimus administration]Yosuke Mukai, Yutaka Takeda, Shin Nakahira, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[A case of neoadjuvant chemotherapy for locally advanced rectal cancer, which had a invasion into the vagina followed by curative resection]Kei Kimura, Yoshinori Kagawa, Takeshi Kato, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[Six synchronous primary cancers - a case report]Tadayoshi Hashimoto, Hirokazu Taniguchi, Atsushi Takeno, et al.Journal of Cancer Research and Clinical Oncology|December 20, 2019
Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancerHisao Imai, Satoshi Wasamoto, Ou Yamaguchi, et al.Nature Communications|February 10, 2026
Targeting NHEJ activates STING signaling through MYC degradation to boost antitumor immunity in SCLCSubhamoy Chakraborty, Andrew Elliott, Utsav Sen, et al.Thoracic Cancer|September 5, 2022
Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survivalKen Masubuchi, Hisao Imai, Satoshi Wasamoto, et al.Thoracic Cancer|December 19, 2019
Phase II study of ramucirumab and docetaxel for previously treated non-small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM studyShinnosuke Takemoto, Minoru Fukuda, Hiroyuki Yamaguchi, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 27, 2012
[A case of primary neuroendocrine carcinoma of the bile duct]Michiko Hamanaka, Shin Nakahira, Yutaka Takeda, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[A case of simultaneous laparoscopic resection of colorectal cancer and a synchronous liver metastasis]Tomo Ishida, Yoshinori Kagawa, Takeshi Kato, et al.The Oncologist|April 5, 2022
Three-Year Outcomes of a Phase II Study of Perioperative Capecitabine Plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601)Jin Matsuyama, Tetsuji Terazawa, Masahiro Goto, et al.Pageof 47